PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.25 (3.448%)
Open: 7.375
High: 7.375
Low: 7.375
Prev. Close: 7.375
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

22 Jul 2010 13:49

RNS Number : 7769P
Phytopharm PLC
22 July 2010
 

 

Annex DTR3

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

 

All relevant boxes should be completed in block capital letters.

 

1.

Name of the issuer

PHYTOPHARM PLC

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

(III)

(iii) BOTH (i) AND (ii)

3.

Name of person discharging managerial

responsibilities/director

MR TIMOTHY SHARPINGTON, CHIEF EXECUTIVE

 

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

AS 3 ABOVE

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

AS 3 ABOVE

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

OPTIONS OVER ORDINARY SHARES OF 1 PENCE EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

8.

State the nature of the transaction

 

 

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

13.

Price per share or value of transaction

 

 

 

14.

Date and place of transaction

 

 

 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

 

 

 

 

 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

 

17.

Date of grant

21 JULY 2010

 

18.

Period during which or date on which exercisable

THESE OPTIONS SHALL BE EXERCISEABLE FROM THE THIRD ANNIVERSARY OF GRANT FOR A PERIOD OF SEVEN YEARS

 

19.

Total amount paid (if any) for grant of the option

NIL

20.

Description of shares or debentures involved (class and number)

3,466,774 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

7.63 PENCE PER SHARE

 

22.

Total number of shares or debentures over which options held following notification

3,466,774 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES

23.

Any additional information

 

24.

Name of contact and telephone number for queries

ZOE MCGOWAN COMPANY SECRETARY 01480 437697

 

 

Name of authorised official of issuer responsible for making notification

ZOE MCGOWAN, COMPANY SECRETARY

Date of notification 22 JULY 2010

 

 

 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRTMTTMBITBIM
Date   Source Headline
17th Jan 20177:00 amRNSAppointment of Giulio Cerroni as CEO
16th Jan 20172:00 pmRNSAnnual Report and Accounts and Notice of AGM
13th Jan 20173:25 pmRNSHolding(s) in Company
12th Jan 20172:56 pmRNSHolding(s) in Company
4th Jan 20173:43 pmRNSIssue of 590,093 Deferred Consideration Shares
23rd Dec 20167:00 amRNSBuyback and Cancellation of Deferred Shares
20th Dec 20167:00 amRNSFull Year Results
16th Nov 20167:00 amRNSParticipation in major EU partnership (ROADMAP)
21st Oct 20167:00 amRNSPre-Close Trading Update
20th Oct 20167:00 amRNS$1.2m contract with new global pharma customer
19th Oct 20167:00 amRNSIXICO presents at CAMD regulatory workshop
10th Oct 20167:00 amRNSEUR1m funding as a partner in major EU consortium
3rd Oct 20167:00 amRNSAppointment of Shore Capital as Nominated Adviser
3rd Oct 20167:00 amRNSAppointment of Shore Capital
26th Sep 20165:14 pmRNSDirector/PDMR Shareholding
26th Sep 20161:58 pmRNSExercise of Share Options
16th Sep 20167:00 amRNSBoard changes
13th Sep 20167:00 amRNSPresentation of Assessa® PML at ECTRIMS
29th Jul 201610:25 amRNSWeb-Based Technology Improves Paediatric ADHD Care
7th Jun 20167:00 amRNSHalf Yearly Report to 31 March 2016
2nd Jun 20167:00 amRNSCygnus joins Dementias Platform UK
4th Apr 20167:00 amRNSConsortium and Five Year Contract
31st Mar 20167:00 amRNSReal world study of Digital Biomarkers
31st Mar 20167:00 amRNSGrant of Awards to Directors
30th Mar 20167:00 amRNSNHS emergency and out-of-hours services contract
9th Mar 20169:30 amRNSEuropean research to tackle dementia
3rd Mar 20167:00 amRNSMehealth® used in American Academy of Pediatrics
1st Mar 201610:35 amRNSDirector/PDMR Shareholding
5th Feb 20167:00 amRNSDirector/PDMR Shareholding
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
29th Jan 201610:45 amRNSResult of AGM
29th Jan 20167:00 amRNSAGM Statement
22nd Jan 20167:00 amRNSSelected for two NHS Innovation Test Beds
21st Jan 20167:00 amRNSMyBrainBook wins Regional Business Award
18th Jan 20167:00 amRNSFour contracts awarded worth over £3.0m
7th Jan 20167:00 amRNSFinancial Results for the year ended 30 Sept 2015
21st Dec 20152:03 pmRNSUpdate on Issued Share Capital
7th Dec 201510:04 amRNSResult of General Meeting
18th Nov 20153:45 pmRNSPublication of Circular
18th Nov 20157:00 amRNSProposed acquisition of Optimal Medicine & placing
2nd Nov 20153:38 pmRNSTotal Voting Rights
19th Oct 20157:00 amRNSPre-Close Trading Update
12th Oct 20151:16 pmRNSAdditional Listing
9th Oct 20157:00 amRNSCollaboration with leading pharmaceutical co in MS
2nd Oct 201511:18 amRNSExercise of Share Options
28th Aug 20157:00 amRNSIXICO awarded significant long-term contract
29th Jun 20157:00 amRNSVirtualScopics Alliance Update
25th Jun 20151:21 pmRNSHolding(s) in Company
26th May 20157:01 amRNSRelease of beta version of MyBrainBook®
12th May 20157:00 amRNSLaunch of UK Government funded project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.